Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial
Major surgery can place sudden stress on the body and make the heart beat faster. For some people, this can cause damage to the heart muscle, known as myocardial injury after non-cardiac surgery (MINS). Often, this injury happens quietly without chest pain, but it can still lead to serious health problems later on. This study tests a tablet called ivabradine. Ivabradine works by gently slowing down the heart rate without lowering blood pressure. Doctors hope that keeping the heart rate steady will reduce the strain on the heart during and after an operation. Patients taking part are randomly chosen to receive either ivabradine or a dummy tablet (placebo). Researchers will track participants' heart health, blood tests, and recovery for 30 days after surgery to see if the medicine offers better protection.
At a glance
What is this study about?
When you have an operation that is not on your heart—such as surgery on your tummy, bones, or blood vessels—your body goes through a lot of physical stress. This stress can cause your heart to beat much faster than usual. When the heart works this hard, it needs more oxygen. If it cannot get enough oxygen, the heart muscle can become strained or injured. Doctors call this 'myocardial injury after non-cardiac surgery', or MINS for short.
Many people who develop MINS do not feel any obvious symptoms, like chest pain. Instead, doctors usually spot it through routine blood tests that show tiny proteins called troponins leaking from injured heart cells. Even though you might not feel unwell right away, heart strain after surgery can raise the risk of having a heart attack, a stroke, or needing a longer hospital stay.
This study, called the PREVENT-MINS trial, is looking at whether a tablet called ivabradine can help protect the heart. Ivabradine is an approved medicine that slows down the pulse safely, giving the heart muscle more time to rest between beats. By testing ivabradine against a placebo (a dummy pill), researchers want to learn if slowing the heart rate around the time of surgery helps people recover more safely and avoids damage to the heart.
Key takeaways
- The trial tests whether the heart medicine ivabradine can protect your heart during major non-heart surgery.
- Participants take either ivabradine or a dummy tablet (placebo) around the time of their operation.
- Heart health and general recovery are closely monitored for 30 days after surgery.
- The study aims to prevent silent heart damage, heart attacks, and strokes linked to surgical stress.
- Taking part is voluntary, and you can withdraw at any time without harming your routine care.
Who may be eligible?
This trial is open to adults aged 18 and older who are scheduled to have an operation that does not involve the heart. Because surgery can place extra stress on the body, the study focuses on people who may benefit from extra heart protection during their hospital stay.
Both men and women can join. Your surgical and medical team will check your overall fitness, medical history, and the type of procedure you are having to see if this study is suitable for you.
Certain people may not be able to join. For example, if your resting heart rate is already very slow, if you have specific irregular heart rhythms, or if you take medicines that clash with ivabradine, this trial may not be right for you. Your study doctor will discuss your health details carefully before you decide.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I am scheduled to have an operation that is not on my heart.
- I am willing to take study tablets before and around the time of my surgery.
- I am happy to have my heart rate, blood pressure, and recovery tracked for 30 days.
- I do not have a known allergy to ivabradine or the ingredients in the study capsules.
What does participation involve?
If you agree to take part, you will be placed into one of two groups by chance (like flipping a coin). One group will take ivabradine tablets, and the other group will take matching dummy tablets (placebos). Neither you nor your doctors will know which tablet you are taking, ensuring the results are fair.
You will take the study tablets around the time of your operation, as directed by the research team. During your hospital stay, nurses and doctors will closely monitor your pulse, blood pressure, and heart rhythm. They will also take routine blood tests to look for signs of heart strain. After you go home, the team will check in on your recovery, keeping in touch until about 30 days after your operation to see how well you are feeling and how many days you have spent resting comfortably at home.
Potential risks and benefits
Locations (1)
- —UnverifiedPoland
Common questions
What is a placebo?
A placebo is a dummy tablet that looks and tastes exactly like the study medicine but contains no active ingredients. It helps researchers prove whether the real medicine actually works.
Will taking part delay my surgery?
No, taking part is planned around your normal hospital care and should not delay your scheduled operation.
What are phosphenes?
Phosphenes are harmless visual sensations, like temporary spots or flashes of light in your field of vision, which can sometimes happen while taking ivabradine.
Will I have to pay for the study medicine?
No, all study tablets and extra tests linked to the trial are provided free of charge.
Can I leave the study if I change my mind?
Yes. Joining is completely up to you. You can change your mind and stop at any time without your regular medical care being affected.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.